How to build and implement an eQMS: efficiency, compliance and data integrity – Replay

News

Streamlining Medical Device Risk Analysis with GxpManager's Agile Platform

Article published on DeviceMed.

A medical device’s risk analysis is an essential step in ensuring that it complies with current regulations and is safe for users. In this field, digitizing critical data helps ensure data compliance, safety, and reliability.

 

Medical devices are subject to strict regulations (EU 2017/745, ISO14971, 21CFR part 11…) to guarantee their effectiveness and patient safety. In turn, these texts require compliance with demanding standards for medical device design, manufacture, packaging, labeling, and use. The risk analysis process involves studying past risks and identifying and assessing potential threats to determine the measures to minimize these risks.

There are ways in which these can be assessed, including using risk management solutions that identify weak points and draw up mitigation plans to alleviate them. The aim is to ensure that the risks associated with the use of medical devices, whatever their class, are reduced to an acceptable level, and that the benefits of the device outweigh the risks. The risk management process comprises several stages:

  • Risk identification,
  • Assessing them in terms of probability of occurrence and severity,
  • Controlling unaccepted risks by implementing corrective actions,
  • Assessment of residual and/or collateral risks.

This is a critical process. Yet it is often formalized in Excel spreadsheets, which do not comply with current security, data integrity, and traceability regulations.

An agile platform that facilitates audits

GxpManager offers its “Risk Analysis” application to meet this need. This solution includes a set of customizable, compliance-oriented functionalities that are ideally suited to risk analysis of medical devices.

It manages the entire risk management process and automatically publishes the file: identification, assessment, control, acceptability, graphic indicators, etc. The application is customized to each manufacturer’s processes and methods. It features native functionalities such as audit trail, document versioning, workflows with electronic signatures, one-click report publication, and much more…

This agile platform supports manufacturers in the digitization of their critical data. It reduces document management effort, centralizes and shares data, automates processes, enables real-time reporting, and allows controlled publication of risk management files according to manufacturers’ templates.

The message from GxpManager President Jérôme Tomaselli is clear:

“Digitizing the risk analysis process for medical devices can present a daunting challenge, but traceability, compliance, and safety benefits are considerable.”

Other news

News
Digitalization in the Cosmetic Industry: Enhancing Quality and Compliance

Companies are seeking solutions to improve the quality, traceability, and digitalisation of their processes.

Learn more
News
GxpManager at Digital Enterprise Show 2024

Meet our team at booth 1G756 and discuss data strategies to ensure your company complies with the current regulations in your industry.

Learn more
News
GxpManager Participates in SNITEM start-up day 2024

Find GxpManager at booth S11 at the 9th Innovative Start-up Day for Medical Devices, organized by the SNITEM

Learn more
News
Modernization of Cosmetics Regulation Act in the US: Key Changes

MoCRA introduces essential changes in the American cosmetics industry.

Learn more
News
GxpManager attends VivaTechnology 2024 in Paris

Our team will present our data management software and our latest advancements in digitalizing business processes, ensuring full compliance.

Learn more
News
GxpManager will be at the Swiss Biotech Day 2024 in Basel

GxpManager will be participating in the Swiss Biotech Day exhibition, which will take place on April 22nd and 23rd in Basel, Switzerland. Visit booth 70 to learn more about how our compliance-focused digitalization solutions revolutionize the biotechnology sector. Marc and Farida will be there to welcome you.

Learn more
News
Barriers to digitalization: regulatory constraints

Regulatory standards represent a significant obstacle to adopting new technologies; however, digitization of business processes are becoming essential to ensure regulatory compliance for companies subject to stringent regulations.

Learn more
News
GxpManager attends Medi’Nov 2024

Whether you are a SME, a startup, a laboratory, a research and development center... our team is here to support you in transitioning.

Learn more
News
GxpManager – Forum Labo 2024

GxpManager platform offers a comprehensive solution to address laboratories' complex regulatory compliance challenges.

Learn more